Questions? Feedback? powered by Olark live chat software
All Site

A social and networking event by The BioProcessing Network

The Bioprocessing Network Australia (BPN) has selected Probiotics Australia as the site for the next QLD satellite event now that Probiotics Australia has been launched and started production.

 Probiotics Australia is a purpose built, cutting-edge bio-manufacturing facility, located in Ormeau, Queensland, it was officially opened in May 2019. The TGA cGMP licensed facility houses research, development and production laboratories in addition to sizable warehousing and offices. The site is also certified by Australian Certified Organic, HACCP approved, and FDA registered.

Time: 6.00pm – 8.00pm 
Wednesday 18th of September
Location: Probiotics Australia Facility 
24 Blanck Street, Ormeau QLD 4208
RSVP by the 11th of September 

Start with Authenticated Standards

ATCC Pledges to Advance Authentication

Are you willing to stake the integrity of your research on potentially unreliable starting materials? Your incredible advancements are too important to risk.


Next-Generation Biological Models: Revolutionizing Cancer Research

In ATCC's latest short documentary film, “Next-Generation Biological Models: Revolutionizing Cancer Research,” they focus on the Human Cancer Models Initiative (HCMI), a groundbreaking international research collaboration to transform cancer research and therapeutic development.


A new partnership with Polyplus Transfection SA

We are very pleased to announce that Polyplus-transfection® SA, has trusted In Vitro Technologies as their new exclusive distributor in Australia and New Zealand.
Located close to the University of Strasbourg in France, Polyplus-transfection® SA is a biotechnology company that develops and sells innovative, high efficiency transfection reagents for the delivery of nucleic acids in research, bioproduction and therapeutics.


The ATCC Toxicology Portfolio

ATCC's toxicological tools can also be used to identify responses to environmental insults or to screen pharmaceutical compounds. These cells are applicable for bench work and large-scale screening and are fully characterized and  functionally tested.


What’s news from ATCC?

ATCC has updated the White Paper Synthetic Nucleic Acids for the Development and Evaluation of In Vitro Diagnostic Devices Designed to Detect Dengue, Chikungunya, and Zika White Paper.


Eradicate Cancer Travel Grant Winners

To support Australian and New Zealand research in the fight against cancer, In Vitro Technologies offered 5 Travel Grants to Australian and New Zealand researchers to attend the Eradicate Cancer Conference in Melbourne in March 2018. And the winners are...

Total: 58 posts